Bronchitis
50
2
2
33
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.0%
1 terminated out of 50 trials
97.1%
+10.6% vs benchmark
18%
9 trials in Phase 3/4
24%
8 of 33 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 33 completed trials
Clinical Trials (50)
Analysis of the Virtual Acute Care at Home Experience
Evaluation of Effectiveness of the Treatment After Repeated Administration of Klacid®SR
Mepolizumab in Chronic Obstructive Pulmonary Diseases (COPD) With Eosinophilic Bronchitis
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
Development of the Drug and Alcohol Respiratory Health Test
Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Crossover, Single Dose, Two-stage Bioequivalence Study of SCMC-Lys Salt 1.35 g Powder vs SCMC-Lys Salt 90 mg/mL Syrup
Copeptin: Disease Severity Indicator
Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
Sinolpan® Pharmacy Non-interventional Study - Quality of Live
Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)
Multiple Breath Washout, a Clinimetric Dataset
Clinical Validation of Omron WheezeScan
Energy Supply in Athletes and Untrained Persons With Bronchopulmonary Diseases
A Safety Study of Balsamic Bactrim in Pediatric Participants With Acute Bronchitis
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
Fluoroquinolone Associated Disability
An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.
A Non-Interventional Safety Study of Balsamic Bactrim
Prophylactic Efficacy of Relenza Against Influenza A and B